Much has changed technologically since NASA's Galileo mission dropped a probe into Jupiter's atmosphere to investigate, among other things, the heat engine driving the gas giant's atmospheric circulation.
Future Science Group (FSG) has begun supplying full-text articles to Jisc's Publications Router service, enabling onward distribution to institutional repositories.
An innovative wearable sensor to monitor new-born babies in poor areas is being developed by Anglia Ruskin University, in collaboration with experts in Jordan.
The 'Journal of Play in Adulthood' adds to the increasing research in the field of adult playfulness and how people learn.
Eisenhower Health is the first hospital in Southern California to offer a new lung valve treatment for patients with severe COPD/emphysema. The Zephyr Endobronchial Valve treatment represents a major advancement because it is the first minimally invasive procedure to help emphysema sufferers breathe easier without major surgery. Done through a simple bronchoscopy, the valves improve patients' quality of life by allowing them to breathe easier, be less short of breath, and be more active and energetic.
Five new innovators will be joining Chain Reaction Innovations (CRI), the entrepreneurship program at the US Department of Energy's (DOE's) Argonne National Laboratory, as part of the elite program's third cohort. Announced on Monday, April 22, 2019, these innovators were selected following an extensive national solicitation process and two-part pitch competition, with reviews from industry experts, investors, scientists and engineers.
A spray- or brush-applied fire retardant coating made from nanocellulose is well suited for improving the fire properties of wood-based materials. It reduces the access of oxygen to the surface, thus significantly inhibiting combustion.
Gil Hospital and Longenesis enter research collaboration to integrate Health Data Management Solution.
John Wiley and Sons Inc., (NYSE: JW-A) (NYSE: JW-B) is now inviting original research articles for two newly formed open access journals, Genetics & Genomics Next and Neuroscience Next.
Today marks the beginning of a new era in treatment planning at the University Proton Therapy Dresden of the University Hospital in Dresden: for the worldwide first time, a new approach increases the accuracy, safety and probably also the tolerability of proton therapy. The range prediction procedure was developed and extensively validated by medical physicists from the Dresden OncoRay Center, the Helmholtz-Zentrum Dresden-Rossendorf and the German Cancer Research Center in Heidelberg.